Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,179.00p on 14-04-2026 at 15:34:45
Change 9.00p 0.41%
Buy 2,064.00p
Sell 2,396.00p
Last Trade: Sell 3.00 at 2,178.00p
Day's Volume: 2,312,615
Last Close: 2,179.00p
Open: 2,170.00p
ISIN: GB00BN7SWP63
Day's Range 2,164.00p - 2,195.00p
52wk Range: 1,314.00p - 2,282.00p
Market Capitalisation: £87.06b
VWAP: 2,161.3464p
Shares in Issue: 4.00b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 3 2,178.00p SI Trade
16:29:51 - 14-Apr-26
Sell* 457 2,179.00p Automatic Execution
16:29:47 - 14-Apr-26
Sell* 2,712 2,179.00p Automatic Execution
16:29:47 - 14-Apr-26
Buy* 620 2,179.00p Automatic Execution
16:29:32 - 14-Apr-26
Buy* 500 2,179.00p Automatic Execution
16:29:32 - 14-Apr-26
Buy* 573 2,179.00p Automatic Execution
16:29:32 - 14-Apr-26
Buy* 2,712 2,179.00p Automatic Execution
16:29:32 - 14-Apr-26
Buy* 465 2,179.00p Automatic Execution
16:29:32 - 14-Apr-26
Buy* 7 2,179.00p Automatic Execution
16:29:32 - 14-Apr-26
Buy* 42 2,179.00p Automatic Execution
16:29:32 - 14-Apr-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Apr 2026 (Mon) 2,151.00 2,180.00 2,151.00 2,170.00 6,947,099
10th Apr 2026 (Fri) 2,156.00 2,196.00 2,156.00 2,176.00 8,127,125
9th Apr 2026 (Thu) 2,141.00 2,167.00 2,124.00 2,167.00 6,632,002
8th Apr 2026 (Wed) 2,126.00 2,142.00 2,104.00 2,125.00 9,481,975
7th Apr 2026 (Tue) 2,129.00 2,137.00 2,083.00 2,096.00 5,857,080
6th Apr 2026 (Mon) 2,144.00 2,144.00 2,144.00 2,144.00 0
3rd Apr 2026 (Fri) 2,144.00 2,144.00 2,144.00 2,144.00 0
2nd Apr 2026 (Thu) 2,097.00 2,161.00 2,090.00 2,144.00 6,448,889
1st Apr 2026 (Wed) 2,072.00 2,122.00 2,072.00 2,107.00 6,204,094
31st Mar 2026 (Tue) 2,064.00 2,086.00 2,064.00 2,064.00 15,704,368
30th Mar 2026 (Mon) 2,051.00 2,070.00 2,044.00 2,063.00 9,872,668
27th Mar 2026 (Fri) 2,041.00 2,060.00 2,023.00 2,049.00 6,240,777
26th Mar 2026 (Thu) 2,035.00 2,072.00 2,035.00 2,047.00 12,704,366
25th Mar 2026 (Wed) 1,991.50 2,054.00 1,989.50 2,054.00 11,609,628
24th Mar 2026 (Tue) 1,943.50 1,977.00 1,933.00 1,977.00 7,832,345
23rd Mar 2026 (Mon) 1,926.00 1,966.50 1,906.50 1,937.00 12,420,260
20th Mar 2026 (Fri) 1,960.00 1,967.50 1,940.50 1,950.50 14,988,054
19th Mar 2026 (Thu) 1,951.50 1,976.00 1,943.50 1,956.00 7,174,578
18th Mar 2026 (Wed) 2,010.00 2,013.00 1,945.50 1,972.50 8,290,930
17th Mar 2026 (Tue) 2,032.00 2,037.00 2,002.00 2,013.00 11,964,583
16th Mar 2026 (Mon) 2,037.00 2,053.00 2,026.00 2,026.00 6,815,220
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
13th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
13th Apr 2026 7:00 am RNS Transaction in Own Shares
13th Apr 2026 7:00 am RNS GSK presents positive data for BEHOLD 1 B7 H4 ADC
10th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
10th Apr 2026 7:00 am RNS Transaction in Own Shares
9th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
9th Apr 2026 7:00 am RNS Transaction in Own Shares
8th Apr 2026 7:00 am RNS Exdensur approved for CRSwNP in China
8th Apr 2026 7:00 am RNS Transaction in Own Shares
7th Apr 2026 7:00 am RNS Transaction in Own Shares
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON BROKER RATINGS: Bernstein cuts Wizz Air and easyJet

13th Apr 2026 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

GSK posts encouraging data for endometrial and ovarian cancer drug

13th Apr 2026 07:00

(Alliance News) - GSK PLC on Sunday reported positive data for its cancer therapy candidate mocertatug rezetecan. Read More

LONDON MARKET CLOSE: Oil creeps higher amid fragile US-Iran ceasefire

9th Apr 2026 17:07

(Alliance News) - The FTSE 100 nursed modest losses on Thursday as doubts grew over the strength and sustainability of the US-Iran ceasefire. Read More

China approves GSK's Exdensur for treating chronic rhinosinusitis

8th Apr 2026 08:59

(Alliance News) - GSK PLC on Wednesday said its Exdensur drug, has been approved in China as an add-on therapy for the treatment of chronic rhinosinusitis with nasal polyps. Read More

LONDON BRIEFING: Shell trims output view but refining margins climb

8th Apr 2026 07:50

(Alliance News) - Shell says the Middle East conflict hit output in its Integrated Gas arm, though it sees "significantly higher" trading and optimisation results. GSK announces a drug approval in China, while Close Brothers believes the cost of the final motor finance redress can be "comfortably absorbed". Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,600.79
Change17.83

Login to your account

Forgot Password?

Not Registered